Page 102 - 《中国药房》2020年22期

fants：a randomized controlled trial[J]. Pediatrics，2019. regimens on vancomycin target levels in critically ill pa-
DOI：10.1542/peds.2018-2179. tients：continuous versus intermittent application[J]. J In-
[21] HONG LT，GOOLSBY TA，SHERMAN DS，et al. Contin- fect Public Health，2015，8（4）：355-363.
uous infusion vs intermittent vancomycin in neurosurgical [31] VERRALL AJ，LLORIN R，TAM VH，et al. Efficacy of
intensive care unit patients[J]. J Crit Care，2015. DOI： continuous infusion of vancomycin for the outpatient treat-
10.1016/j.jcrc.2015.06.012. ment of methicillin-resistant staphylococcus aureus infec-
[22] HUTSCHALA D，KINSTNER C，SKHIRDLADZE K，et tions[J]. J Antimicrob Chemother，2012，67（12）：2970-
al. Influence of vancomycin on renal function in critically 2973.
ill patients after cardiac surgery：continuous versus inter- [32] VUAGNAT A，STERN R，LOTTHE A，et al. High dose
mittent infusion[J]. Anesthesiology，2009，111（2）：356- vancomycin for osteomyelitis：continuous vs. intermittent
365. infusion[J]. J Clin Pharm Ther，2004，29（4）：351-357.
[23] INGRAM PR，LYE DC，FISHER DA，et al. Nephrotoxici- [33] WYSOCKI M，DELATOUR F，FAURISSON F，et al.
ty of continuous versus intermittent infusion of vancomy- Continuous versus intermittent infusion of vancomycin in
cin in outpatient parenteral antimicrobial therapy[J]. Int J severe staphylococcal infections：prospective multicenter
Antimicrob Agents，2009，34（6）：570-574. randomized study[J]. Antimicrob Agents Chemother，2001.
[24] LIN H，BUKOVSKAYA Y，DE MOYA M，et al. Vancomy- DOI：10.1128/aac.45.9.
cin continuous infusion versus intermittent infusion dur- [34] 杜聪梅.万古霉素持续滴注对血浆药物浓度的影响及临
ing continuous venovenous hemofiltration：slow and 床研究[D].苏州：苏州大学，2017.
steady may win the race[J]. Ann Intensive Care，2015. [35] 郑小娟，程燕燕，吴梅花，等.万古霉素致红人综合征的文
DOI：10.1186/s13613-015-0048-x. 献分析[J].临床合理用药杂志，2019，12（3A）：130-131.
[25] MA NH，WALKER SAN，ELLIGSEN M，et al. Retrospec- [36] 张弨，单爱莲.基于治疗药物监测制定万古霉素给药方案
tive multicentre matched cohort study comparing safety 路径研究[J].中国临床药理学杂志，2017，33（23）：2484-
and efficacy outcomes of intermittent-infusion versus con- 2488.
tinuous-infusion vancomycin[J]. J Antimicrob Chemother， [37] DRENNAN PG，BEGG EJ，GARDINER SJ，et al. The
2020，75（4）：1038-1046. dosing and monitoring of vancomycin：what is the best
[26] VAN MAARSEVEEN EM，GIPMANS S，VASBINDER way forward? [J]. Int J Antimicrob Agents，2019，53（4）：
E，et al. Switching from intermittent to continuous infu- 401-407.
sion of vancomycin in critically ill patients：toward a more [38] 汪复，张婴元.实用抗感染治疗学[M]. 2 版.北京：人民卫
robust exposure[J]. Ther Drug Monit，2016，38（3）：398- 生出版社，2015：130-131.
401. [39] NEELY MN，KATO L，YOUN G，et al. Prospective trial
[27] SAUGEL B，NOWACK MC，HAPFELMEIER A，et al. on the use of trough concentration versus area under the
Continuous intravenous administration of vancomycin in curve to determine therapeutic vancomycin dosing[J]. An-
medical intensive care unit patients[J]. J Crit Care，2013. timicrob Agents Chemother，2018. DOI：10.1128/aac.
DOI：10.1016/j.jcrc.2012，02.003. 02042-17.
[28] SCHMELZER TM，CHRISTMAS AB，NORTON HJ， [40] VAN HAL SJ，PATERSON DL，LODISE TP，et al. Sys-
et al. Vancomycin intermittent dosing versus continuous tematic review and meta-analysis of vancomycin-induced
infusion for treatment of ventilatorassociated pneumonia nephrotoxicity associated with dosing schedules that main-
in trauma patients[J]. Am Surg，2013，79（11）：1185-1190. tain troughs between 15 and 20 milligrams per liter[J]. An-
[29] SHAKERANEH P，FAZILI T，WANG D，et al. Nephro- timicrob Agents Chemother，2013. DOI：10.1128/aac.
toxicity risk and clinical effectiveness of continuous ver- 01568-12.
sus intermittent infusion vancomycin among patients in an [41] 刘玉美.抗生素治疗感染性疾病失败的常见原因分析[J].
outpatient parenteral antimicrobial therapy program[J]. 山东医药，2007，47（25）：104.
Pharmacotherapy，2020，40（4）：357-362. （收稿日期：2020-05-26 修回日期：2020-09-19）
[30] TAFELSKI S，NACHTIGALL I，TROEGER U，et al. Ob- （编辑：陈 宏）
servational clinical study on the effects of different dosing

·2780 · China Pharmacy 2020 Vol. 31 No. 22 中国药房 2020年第31卷第22期